Skip to content

Study on an anxiety treatment protocol

Effect of V-CALM protocol in patients with anxiety disorders A Pretest-Posttest design. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087627
Enrollment
32
Registered
2025-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders

Interventions

None listed

Sponsors

Dr Sheela Karalam B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of mild-moderate anxiety disorders (Ham -A 18-24) as per Hamilton anxiety rating scale.

Exclusion criteria

Exclusion criteria: Those under allopathic medication for generalised anxiety disorders. Those having other comorbid psychiatric conditions. Substance abuse, pregnancy and lactating mothers. Those having significant medical conditions that may interfere with the practice of the protocol

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Rating Scale Quality of life assessment using Q-LES-Q-SF scale Insomnia severity indexTimepoint: 0th day, after the last day of medication and the 70th day of the follow up follow-up period

Secondary

MeasureTime frame
not applicableTimepoint: not applicable

Countries

India

Contacts

Public ContactDr Dileep K S

Vaidyaratnam Ayurveda Foundation

adithyaksreedhar@gmail.com9447303675

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026